Total Funding
9
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3060806
BioMimetic Therapeutics is a provider of orthopedic consultation and health care to patients.
Acquired by 
Wright Medical Group
Lawrence E. Bullock: Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
About the Company
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions,
the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse.
BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.
